Reduction in Circulating Advanced Glycation End Products by Mediterranean Diet Is Associated with Increased Likelihood of Type 2 Diabetes Remission in Patients with Coronary Heart Disease: From the Cordioprev Study.


Journal

Molecular nutrition & food research
ISSN: 1613-4133
Titre abrégé: Mol Nutr Food Res
Pays: Germany
ID NLM: 101231818

Informations de publication

Date de publication:
01 2021
Historique:
received: 18 12 2019
revised: 01 06 2020
pubmed: 13 6 2020
medline: 28 9 2021
entrez: 13 6 2020
Statut: ppublish

Résumé

It is hypothesized that decreased advanced glycation end products (AGEs) levels could affect type 2 diabetes mellitus (T2DM) remission in newly diagnosed patients through the consumption of two healthy diets. Patients from CORDIOPREV study, all with previous cardiovascular events, with T2DM at the beginning of the study are included. Patients are randomized to a Mediterranean or a low-fat diet for five years. No different diabetes remission rates are found among diets. Serum methylglioxal (MG) and carboximethyllysine (CML), levels dietary AGE, as well as gene expression of AGER1 and RAGE are measured. Serum MG decreases only after the consumption of the Mediterranean diet. Moreover, a COX regression analysis shows that each SD decrease in the MG, occurring after the Mediterranean diet, increases the probability of T2DM remission with HR:2.56(1.02-6.25) and p = 0.046 and each SD increase in disposition index at baseline increases the probability of remission with HR:1.94(1.32-2.87) and p = 0.001. It is demonstrated that the reduction of serum AGEs levels and the modulation of its metabolism, occurring after the consumption of a Mediterranean diet, might be involved in the molecular mechanism underlying the T2DM remission of newly diagnosed patients with coronary heart disease.

Identifiants

pubmed: 32529753
doi: 10.1002/mnfr.201901290
doi:

Substances chimiques

AGER protein, human 0
Antigens, Neoplasm 0
Glycation End Products, Advanced 0
Receptor for Advanced Glycation End Products 0
Pyruvaldehyde 722KLD7415
MOK protein, human EC 2.7.11.22
Mitogen-Activated Protein Kinases EC 2.7.11.24

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1901290

Informations de copyright

© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

S. L. James, D. Abate, K. H. Abate, S. M. Abay, C. Abbafati, N. Abbasi, H. Abbastabar, F. Abd-Allah, J. Abdela, A. Abdelalim, I. Abdollahpour, R. S. Abdulkader, Z. Abebe, S. F. Abera, O. Z. Abil, H. N. Abraha, L. J. Abu-Raddad, N. M. E. Abu-Rmeileh, M. M. K. Accrombessi, D. Acharya, P. Acharya, I. N. Ackerman, A. A. Adamu, O. M. Adebayo, V. Adekanmbi, O. O. Adetokunboh, M. G. Adib, J. C. Adsuar, K. A. Afanvi, M. Afarideh, et al., Lancet 2018, 392, 1789.
World Health Organization, WHO recommendations on antenatal care for a positive pregnancy experience, World Health Organization, Geneva 2016.
M. Ezzati, E. Riboli, N. Engl. J. Med. 2013, 369, 954.
H. Kolb, S. Martin, BMC Med. 2017, 15, 131.
R. M. van Dam, Eur. J. Epidemiol. 2003, 18, 1115.
K. Esposito, C. M. Kastorini, D. B. Panagiotakos, D. Giugliano, Metab. Syndr. Relat. Disord. 2010, 8, 471.
S. H. Ley, O. Hamdy, V. Mohan, F. B. Hu, Lancet 2014, 383, 1999.
O. Ajala, P. English, J. Pinkney, Am. J. Clin. Nutr. 2013, 97, 505.
R. Casas, S. Castro-Barquero, R. Estruch, E. Sacanella, Int. J. Mol. Sci. 2018, 19, 3988.
E. L. Lim, K. G. Hollingsworth, B. S. Aribisala, M. J. Chen, J. C. Mathers, R. Taylor, Diabetologia 2011, 54, 2506.
S. Steven, K. G. Hollingsworth, A. Al-Mrabeh, L. Avery, B. Aribisala, M. Caslake, R. Taylor, Diabetes Care 2016, 39, 808.
K. Esposito, M. I. Maiorino, M. Petrizzo, G. Bellastella, D. Giugliano, Diabetes Care 2014, 37, 1824.
K. Esposito, M. I. Maiorino, G. Bellastella, D. B. Panagiotakos, D. Giugliano, Endocrine 2017, 56, 27.
K. Nowotny, T. Jung, A. Hohn, D. Weber, T. Grune, Biomolecules 2015, 5, 194.
M. Fournet, F. Bonte, A. Desmouliere, Aging Dis. 2018, 9, 880.
S. Y. Goh, M. E. Cooper, J. Clin. Endocrinol. Metab. 2008, 93, 1143.
J. Uribarri, W. Cai, O. Sandu, M. Peppa, T. Goldberg, H. Vlassara, Ann. N. Y. Acad. Sci. 2005, 1043, 461.
J. Uribarri, S. Woodruff, S. Goodman, W. Cai, X. Chen, R. Pyzik, A. Yong, G. E. Striker, H. Vlassara, J. Am. Dietetic Assoc. 2010, 110, 911.
J. Uribarri, W. Cai, M. Ramdas, S. Goodman, R. Pyzik, X. Chen, L. Zhu, G. E. Striker, H. Vlassara, Diabetes Care 2011, 34, 1610.
J. Lopez-Moreno, G. M. Quintana-Navarro, A. Camargo, R. Jimenez-Lucena, J. Delgado-Lista, C. Marin, F. J. Tinahones, G. E. Striker, H. M. Roche, P. Perez-Martinez, J. Lopez-Miranda, E. M. Yubero-Serrano, Mol. Nutr. Food Res. 2017, 61, 1601029.
J. Lopez-Moreno, G. M. Quintana-Navarro, J. Delgado-Lista, A. Garcia-Rios, N. Delgado-Casado, A. Camargo, P. Perez-Martinez, G. E. Striker, F. J. Tinahones, F. Perez-Jimenez, J. Lopez-Miranda, E. M. Yubero-Serrano, J. Am. Geriat. Soc. 2016, 64, 901.
R. Taylor, A. Al-Mrabeh, S. Zhyzhneuskaya, C. Peters, A. C. Barnes, B. S. Aribisala, K. G. Hollingsworth, J. C. Mathers, N. Sattar, M. E. J. Lean, Cell Metab. 2018, 28, 667.
S. Steven, P. E. Carey, P. K. Small, R. Taylor, Diabet. Med. 2015, 32, 47.
M. E. Lean, W. S. Leslie, A. C. Barnes, N. Brosnahan, G. Thom, L. McCombie, C. Peters, S. Zhyzhneuskaya, A. Al-Mrabeh, K. G. Hollingsworth, A. M. Rodrigues, L. Rehackova, A. J. Adamson, F. F. Sniehotta, J. C. Mathers, H. M. Ross, Y. McIlvenna, R. Stefanetti, M. Trenell, P. Welsh, S. Kean, I. Ford, A. McConnachie, N. Sattar, R. Taylor, Lancet 2018, 391, 541.
E. Ferrannini, G. Mingrone, Diabetes Care 2009, 32, 514.
M. Uusitupa, Lancet 2018, 391, 515.
J. Lindstrom, M. Peltonen, J. G. Eriksson, P. Ilanne-Parikka, S. Aunola, S. Keinanen-Kiukaanniemi, M. Uusitupa, J. Tuomilehto, Diabetologia 2013, 56, 284.
J. Frijhoff, P. G. Winyard, N. Zarkovic, S. S. Davies, R. Stocker, D. Cheng, A. R. Knight, E. L. Taylor, J. Oettrich, T. Ruskovska, A. C. Gasparovic, A. Cuadrado, D. Weber, H. E. Poulsen, T. Grune, H. H. Schmidt, P. Ghezzi, Antioxid. Redox Signaling 2015, 23, 1144.
F. Giacco, M. Brownlee, Circ. Res. 2010, 107, 1058.
E. J. Henriksen, M. K. Diamond-Stanic, E. M. Marchionne, Free Rad. Biol. Med. 2011, 51, 993.
J. L. Leahy, Arch. Med. Res. 2005, 36, 197.
H. Vlassara, J. Uribarri, Curr. Diabetes Rep. 2014, 14, 453.
K. C. Tan, S. W. Shiu, Y. Wong, X. Tam, Diabetes/Metab. Res. Rev. 2011, 27, 488.
A. S. Cheng, Y. H. Cheng, C. Y. Lee, C. Y. Chung, W. C. Chang, Nutrients 2015, 7, 2850.
J. You, Z. Wang, S. Xu, W. Zhang, Q. Fang, H. Liu, L. Peng, T. Deng, J. Lou, J. Diabetes Res. 2016, 2016, 9073037.
R. Blanco-Rojo, J. F. Alcala-Diaz, S. Wopereis, P. Perez-Martinez, G. M. Quintana-Navarro, C. Marin, J. M. Ordovas, B. van Ommen, F. Perez-Jimenez, J. Delgado-Lista, J. Lopez-Miranda, Diabetologia 2016, 59, 67.
J. Delgado-Lista, P. Perez-Martinez, A. Garcia-Rios, J. F. Alcala-Diaz, A. I. Perez-Caballero, F. Gomez-Delgado, F. Fuentes, G. Quintana-Navarro, F. Lopez-Segura, A. M. Ortiz-Morales, N. Delgado-Casado, E. M. Yubero-Serrano, A. Camargo, C. Marin, F. Rodriguez-Cantalejo, P. Gomez-Luna, J. M. Ordovas, J. Lopez-Miranda, F. Perez-Jimenez, Am. Heart J. 2016, 177, 42.
American Diabetes Association, Diabetes Care 2014, 37, S81.
P. Aschner, Diabetes Res. Clin. Pract. 2017, 132, 169.
J. B. Buse, S. Caprio, W. T. Cefalu, A. Ceriello, S. Del Prato, S. E. Inzucchi, S. McLaughlin, G. L. Phillips, 2nd, R. P. Robertson, F. Rubino, R. Kahn, M. S. Kirkman, Diabetes Care 2009, 32, 2133.
G. M. Quintana-Navarro, J. F. Alcala-Diaz, J. Lopez-Moreno, I. Perez-Corral, A. Leon-Acuna, J. D. Torres-Pena, O. A. Rangel-Zuniga, A. P. A. de Larriva, A. Corina, A. Camargo, E. M. Yubero-Serrano, F. Rodriguez-Cantalejo, A. Garcia-Rios, R. M. Luque, J. M. Ordovas, P. Perez-Martinez, J. Lopez-Miranda, J. Delgado-Lista, Eur. J. Nutr. 2019.
M. Matsuda, R. A. DeFronzo, Diabetes Care 1999, 22, 1462.
I. Roncero-Ramos, R. Jimenez-Lucena, J. F. Alcala-Diaz, C. Vals-Delgado, A. P. Arenas-Larriva, O. A. Rangel-Zuniga, A. Leon-Acuna, M. M. Malagon, J. Delgado-Lista, P. Perez-Martinez, J. M. Ordovas, A. Camargo, J. Lopez-Miranda, J. Nutr. Biochem. 2018, 62, 247.
P. J. Thornalley, General Pharmacol. Vascul. Syst. 1996, 27, 565.
S. Arsov, R. Graaff, W. van Oeveren, B. Stegmayr, A. Sikole, G. Rakhorst, A. J. Smit, Clin. Chem. Lab. Med. 2014, 52, 11.
W. Cai, Q. D. Gao, L. Zhu, M. Peppa, C. He, H. Vlassara, Mol. Med. 2002, 8, 337.
W. Cai, M. Ramdas, L. Zhu, X. Chen, G. E. Striker, H. Vlassara, Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 15888.
H. Vlassara, W. Cai, S. Goodman, R. Pyzik, A. Yong, X. Chen, L. Zhu, T. Neade, M. Beeri, J. M. Silverman, L. Ferrucci, L. Tansman, G. E. Striker, J. Uribarri, J. Clin. Endocrinol. Metab. 2009, 94, 4483.

Auteurs

Francisco M Gutierrez-Mariscal (FM)

Maimonines Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, 14004, Spain.
Hospital Universitario Reina Sofia (HURS), Córdoba, 14004, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, 28029, Spain.
Lipids and Atherosclerosis Unit, Reina Sofia University Hospital, University of Córdoba, Córdoba, 14004, Spain.

Magdalena P Cardelo (MP)

Maimonines Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, 14004, Spain.
Hospital Universitario Reina Sofia (HURS), Córdoba, 14004, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, 28029, Spain.
Lipids and Atherosclerosis Unit, Reina Sofia University Hospital, University of Córdoba, Córdoba, 14004, Spain.

Silvia de la Cruz (S)

Maimonines Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, 14004, Spain.
Hospital Universitario Reina Sofia (HURS), Córdoba, 14004, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, 28029, Spain.
Lipids and Atherosclerosis Unit, Reina Sofia University Hospital, University of Córdoba, Córdoba, 14004, Spain.

Juan F Alcala-Diaz (JF)

Maimonines Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, 14004, Spain.
Hospital Universitario Reina Sofia (HURS), Córdoba, 14004, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, 28029, Spain.
Lipids and Atherosclerosis Unit, Reina Sofia University Hospital, University of Córdoba, Córdoba, 14004, Spain.

Irene Roncero-Ramos (I)

Maimonines Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, 14004, Spain.
Hospital Universitario Reina Sofia (HURS), Córdoba, 14004, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, 28029, Spain.
Lipids and Atherosclerosis Unit, Reina Sofia University Hospital, University of Córdoba, Córdoba, 14004, Spain.

Ipek Guler (I)

Maimonines Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, 14004, Spain.
Hospital Universitario Reina Sofia (HURS), Córdoba, 14004, Spain.
Department of Innovation and Methodology, IMIBIC, Córdoba, 14004, Spain.

Cristina Vals-Delgado (C)

Maimonines Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, 14004, Spain.
Hospital Universitario Reina Sofia (HURS), Córdoba, 14004, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, 28029, Spain.
Lipids and Atherosclerosis Unit, Reina Sofia University Hospital, University of Córdoba, Córdoba, 14004, Spain.

Alejandro López-Moreno (A)

Maimonines Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, 14004, Spain.
Hospital Universitario Reina Sofia (HURS), Córdoba, 14004, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, 28029, Spain.
Lipids and Atherosclerosis Unit, Reina Sofia University Hospital, University of Córdoba, Córdoba, 14004, Spain.

Raul M Luque (RM)

Maimonines Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, 14004, Spain.
Hospital Universitario Reina Sofia (HURS), Córdoba, 14004, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, 28029, Spain.
Department of Cell Biology, Physiology, and Immunology, University of Cordoba, Córdoba, 14071, Spain.

Javier Delgado-Lista (J)

Maimonines Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, 14004, Spain.
Hospital Universitario Reina Sofia (HURS), Córdoba, 14004, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, 28029, Spain.
Lipids and Atherosclerosis Unit, Reina Sofia University Hospital, University of Córdoba, Córdoba, 14004, Spain.

Pablo Perez-Martinez (P)

Maimonines Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, 14004, Spain.
Hospital Universitario Reina Sofia (HURS), Córdoba, 14004, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, 28029, Spain.
Lipids and Atherosclerosis Unit, Reina Sofia University Hospital, University of Córdoba, Córdoba, 14004, Spain.

Elena M Yubero-Serrano (EM)

Maimonines Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, 14004, Spain.
Hospital Universitario Reina Sofia (HURS), Córdoba, 14004, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, 28029, Spain.
Lipids and Atherosclerosis Unit, Reina Sofia University Hospital, University of Córdoba, Córdoba, 14004, Spain.

Jose Lopez-Miranda (J)

Maimonines Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, 14004, Spain.
Hospital Universitario Reina Sofia (HURS), Córdoba, 14004, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, 28029, Spain.
Lipids and Atherosclerosis Unit, Reina Sofia University Hospital, University of Córdoba, Córdoba, 14004, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH